Stephen J. Teach, MD, MPH, Peter J. Gergen, MD, MPH, Stanley J

Slides:



Advertisements
Similar presentations
Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Advertisements

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.
Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.
Journal of Allergy and Clinical Immunology
Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1 year of age in an inner-city birth cohort (Urban.
Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection  Howard M. Rosenblatt,
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,
Neighborhood poverty, urban residence, race/ethnicity, and asthma: Rethinking the inner-city asthma epidemic  Corinne A. Keet, MD, PhD, Meredith C. McCormack,
Winter birth in inner-city asthmatic children is associated with increased food allergen sensitization risk  J. Andrew Bird, MD, Julie Wang, MD, Cynthia.
Jonathan Malka, MD, David T
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes  Annette T. Hastie, PhD, Wendy C. Moore,
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Asthma phenotypes in inner-city children
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses  Linus Grabenhenrich, MD, MPH, Lars Lange, MD, Magdalena.
Is 9 more than 2 also in allergic airway inflammation?
Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents  Christine A. Sorkness, PharmD, Jeremy J. Wildfire,
Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey   Päivi M. Salo, PhD, Agustin.
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Katherine A. Vierk, MPH, Kathleen M. Koehler, PhD, MPH, Sara B
Allergy testing in predicting outcome of open food challenge to peanut
The Editors’ Choice Journal of Allergy and Clinical Immunology
Physician needs in health informatics: Just ask the docs
Andrew H. Liu, MD, Denise C. Babineau, PhD, Rebecca Z
DNA methylation and childhood asthma in the inner city
Peter M. Wolfgram, MD, David B. Allen, MD 
George T. O'Connor, MD, MS, Susan V. Lynch, PhD, Gordon R
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Ronald L. Sorkness, PhD, Edward M
High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects  William Busse, MD, Sheldon Spector, MD, Karin Rosén,
Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults  Meghan F. Davis, PhD, Roger D. Peng, PhD,
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
What is an “eosinophilic phenotype” of asthma?
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Robert A. Wood, MD, Alkis Togias, MD, Jeremy Wildfire, MS, Cynthia M
Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1 year of age in an inner-city birth cohort (Urban.
Influence of early-life exposures on food sensitization and food allergy in an inner-city birth cohort  Emily C. McGowan, MD, Gordon R. Bloomberg, MD,
The Editors' Choice Journal of Allergy and Clinical Immunology
Higher incidence of pediatric anaphylaxis in northern areas of the United States  William J. Sheehan, MD, Dionne Graham, PhD, Lin Ma, MS, Sachin Baxi,
Geographic variability in childhood asthma prevalence in Chicago
Jacqueline A. Pongracic, MD, Rebecca Z. Krouse, MS, Denise C
Effect of aging on sputum inflammation and asthma control
Asthma control, adiposity, and adipokines among inner-city adolescents
Corinne A. Keet, MD, MS, Wayne G. Shreffler, MD, PhD, Roger D
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Acute respiratory health effects of air pollution on children with asthma in US inner cities  George T. O'Connor, MD, MS, Lucas Neas, DSc, Benjamin Vaughn,
Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States  Jonathan I. Silverberg, MD, PhD, MPH, Marc.
National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey  
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection  Howard M. Rosenblatt,
Association of obesity with IgE levels and allergy symptoms in children and adolescents: Results from the National Health and Nutrition Examination Survey.
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Personal and parental nativity as risk factors for food sensitization
Environmental factors and eosinophilic esophagitis
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
Neighborhood poverty, urban residence, race/ethnicity, and asthma: Rethinking the inner-city asthma epidemic  Corinne A. Keet, MD, PhD, Meredith C. McCormack,
Modeling asthma exacerbations through lung function in children
Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents  Jeremy J. Wildfire, MS, Peter.
Presentation transcript:

Seasonal risk factors for asthma exacerbations among inner-city children  Stephen J. Teach, MD, MPH, Peter J. Gergen, MD, MPH, Stanley J. Szefler, MD, Herman E. Mitchell, PhD, Agustin Calatroni, MA, MS, Jeremy Wildfire, MS, Gordon R. Bloomberg, MD, Carolyn M. Kercsmar, MD, MS, Andrew H. Liu, MD, Melanie M. Makhija, MD, Elizabeth Matsui, MD, Wayne Morgan, MD, CM, George O'Connor, MD, MS, William W. Busse, MD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 6, Pages 1465-1473.e5 (June 2015) DOI: 10.1016/j.jaci.2014.12.1942 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Univariate associations of baseline predictors (total IgE levels, specific IgE levels, number of positive skin test results, and eosinophil counts) and previous season predictors (FEV1/FVC ratio, Feno value, exacerbation in the previous season, and ICS step requirement) with the probability of exacerbation by season. Solid lines are for marginally significant associations (P < .10), and dashed lines are for nonsignificant associations. Journal of Allergy and Clinical Immunology 2015 135, 1465-1473.e5DOI: (10.1016/j.jaci.2014.12.1942) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Multivariate models for associations of baseline and previous season predictors of exacerbations. Baseline predictors were allergy (skin test results and total IgE levels) and age. Previous season predictors were FEV1/FVC ratio, Feno value, exacerbation history, and ICS step requirement. The length and color of the bars indicate the strength of association between the predictor and seasonal exacerbation, as measured by variance explained. The total predictive power of a multivariate model containing all 7 predictors is annotated in the bottom right corner. Negative associations are indicated with an asterisk. Journal of Allergy and Clinical Immunology 2015 135, 1465-1473.e5DOI: (10.1016/j.jaci.2014.12.1942) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Seasonal exacerbation prevalence by risk level. Each participant had an exacerbation risk level calculated for each season using a simple index of 7 risk factors (allergy, age, FEV1/FVC ratio, Feno value, exacerbation in the previous season, and ICS step requirement). Seasonal risk levels were then divided into tertiles (labeled Low, Medium, and High), which are plotted against observed exacerbation rates in the ACE and ICATA studies. An additional risk group (Very High) was added for participants with a risk index in the top 10%. Journal of Allergy and Clinical Immunology 2015 135, 1465-1473.e5DOI: (10.1016/j.jaci.2014.12.1942) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions